Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares DTX1, A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies, Sascha Dietrich, BTG2 and the tag heme.
Shares Ulm University Hospital / Comprehensive Cancer Center Ulm, Thioredoxin reductase 1, Beckman Coulter, A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies and the tag heme.
Shares A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies, A watch-and-wait registry for blood precursor conditions found by chance, Human normal immunoglobulin (IVIg), BTG1 and the tag heme.
Shares A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies, CTX112, Kartos Therapeutics, KRT-232 and the tag heme.
Shares Alfred Health / Monash University, ICP-248, Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19), Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom.
Shares TG Therapeutics, PIK3CG, SecuraBio, Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19).
Shares Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom, IGHV mutational status, MYD88, Clinical lymphoma, myeloma & leukemia.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.